Both in Biotechnology
Iovance Biotherapeutics vs Relay Therapeutics
Over the past year IOVA returned +348.2% and RLAY returned +156.2%; their daily moves had a correlation of 0.29.
IOVA +348.2% RLAY +156.2%Growth of $1, one year, split-adjusted
| Metric | IOVA | RLAY |
|---|---|---|
| Price | $8.74 | $17.78 |
| Market cap | $3.96B | $3.90B |
| Today | +8.97% | +2.89% |
| 1 month | −38.2% | −8.3% |
| 6 months | +119.6% | +36.8% |
| Year to date | +220.1% | +110.2% |
| 1 year | +343.6% | +149.0% |
| Revenue growth (YoY) | +65.7% | −48.3% |
| Gross margin | 56.1% | 100.0% |
| Net margin | −47.6% | −23916.3% |
| P/E (TTM) | — | — |
| Price / sales | 12.2× | 376.5× |
| Net cash | $297.7M | $910.9M |
| Dividend yield | — | — |
| Volatility (60d) | 129.9% | 49.0% |
| Short % of float | 15.2% | 27.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).